Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shouming Wang is active.

Publication


Featured researches published by Shouming Wang.


Bioorganic & Medicinal Chemistry Letters | 2002

Studies on Quinazolinones as Dual Inhibitors of Pgp and MRP1 in Multidrug Resistance

Shouming Wang; Hamish Ryder; Ian Andrew Pretswell; Paul Depledge; John Milton; Timothy C. Hancox; Ian Dale; Wendy Dangerfield; Peter Charlton; Richard Faint; Rory Dodd; Stephanie Hassan

The syntheses and SAR studies of various quinazolinone compounds are described for the dual inhibition of Pgp and MRP1 in multidrug resistance.


Bioorganic & Medicinal Chemistry Letters | 2002

Novel inhibitors of plasminogen activator inhibitor-1: Development of new templates from diketopiperazines

Shouming Wang; Julian Golec; Warren Miller; Sandra Milutinovic; Adrian John Folkes; Susannah Williams; Teresa Brooks; Kevin Hardman; Peter Charlton; Stephen Paul Wren; John Spencer

Several isoquinoline-based templates were identified from the studies of the conformational effects of the diketopiperazine structures for PAI-1 inhibition. Moderate to good activity was retained with the elimination of unattractive characteristics in the diketopiperazine template.


Bioorganic & Medicinal Chemistry Letters | 2002

Design, synthesis and in vitro evaluation of potent, novel, small molecule inhibitors of plasminogen activator inhibitor-1.

Adrian Folkes; S. David Brown; Lynne Canne; Jocelyn Chan; Erin Engelhardt; Sergey Epshteyn; Richard Faint; Julian Golec; Art Hanel; Patrick Kearney; James W. Leahy; Morrison B. Mac; David A. Matthews; Michael P. Prisbylla; Jason Terry Sanderson; Reyna J. Simon; Zerom Tesfai; Nigel Vicker; Shouming Wang; Robert R. Webb; Peter Charlton

We have synthesized and evaluated a series of tetramic acid-based and hydroxyquinolinone-based inhibitors of plasminogen activator inhibitor-1 (PAI-1). These studies resulted in the identification of several compounds which showed excellent potency against PAI-1. The design, synthesis and SAR of these compounds are described.


The ninth international symposium on resonance ionization spectroscopy:New directions and applications | 1998

Higher Rydberg states of C6H6, C6D6 and C6H5F studied by two-photon resonance ionization spectroscopy

Shouming Wang; R. J. Donovan; T. Ridley; K. P. Lawley

The higher Rydberg states of jet-cooled C6H6, C6D6(n⩽30) and C6H5F(n⩽13) have been studied using two-photon resonance-enhanced multiphoton ionization (REMPI) spectroscopy. In C6H6 and C6D6 long series of three gerade nd Rydberg series converging on the first ionization potential, previously observed up to n=8, are extended up to n=30. The spectra are dominated by origin transitions with only weak vibrational structure being observed. The series with A1g and E1g or E2g symmetry were distinguished by polarization experiments. Similar long series of three nd Rydberg states are also observed for C6H5F and are reported here for the first time. In contrast to benzene, more vibrational activity, especially in ν6a was observed, and thus Rydberg series can only be resolved up to n=12 for C6H5F.


The ninth international symposium on resonance ionization spectroscopy:New directions and applications | 1998

Formation of O2(b 1Σg+) in the ultraviolet photolysis of O3

Patrick O’Keeffe; Trevor Ridley; Shouming Wang; K.P. Lawley; R.J. Donovan

The formation of O2(b 1Σg+) in the ultraviolet photodissociation of O3 (335–352 nm) has been observed for the first time using (2+1) resonance enhanced multiphoton ionization. Measurement of the photofragment kinetic energy confirms that the primary photodissociation step involves the absorption of a single photon.


1997 SPIE Conference on Applications of X Ray Generated From Lasers and Other Bright Sources | 1997

Continuously tunable high-flux VUV beamline constructed on a picosecond KrF laser plasma source

R. Allott; I. C. Edmond Turcu; N. Lisi; John J. Spencer; Waseem Shaikh; Adam Whybrew; Shouming Wang; R. Donovan; K. Lawley; K.W.D. Ledingham; M. Folkard; Kevin Prise

Leading edge research in molecular dynamics, photoelectron spectroscopy, surface interactions and radiobiology has pushed forward the requirement for intense, pulsed, tunable sources of vacuum ultraviolet radiation. Presently, only synchrotron radiation sources are sufficiently bright for these applications. A bright, continuously tunable VUV beamline capable of delivering in excess of 1013 photons/sec/cm2/1nm BW 100 nm, 50 Hz repetition rate (BW equals (Delta) (lambda) /(lambda) is the bandwidth) to the sample, has been constructed on a plasma source generated by a high repetition rate, picosecond KrF excimer laser system.


Journal of Medicinal Chemistry | 2002

Novel angular benzophenazines: dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents.

Nigel Vicker; Luke Burgess; Irina Chuckowree; Rory Dodd; Adrian Folkes; David J. Hardick; Timothy C. Hancox; Warren Miller; John Milton; Sukhjit Sohal; Shouming Wang; Stephen Paul Wren; Peter Charlton; Wendy Dangerfield; Chris Liddle; Prakash Mistry; and Alistair J. Stewart; William A. Denny


Journal of Medicinal Chemistry | 2004

Studies on Pyrrolopyrimidines as Selective Inhibitors of Multidrug-Resistance- Associated Protein in Multidrug Resistance

Shouming Wang; Adrian Folkes; Irina Chuckowree; Xiao-Ling Fan Cockcroft; Sukhjit Sohal; Warren Miller; John Milton; Stephen Paul Wren; Nigel Vicker; Paul Depledge; John W. Scott; Lyndsay Smith; Hazel Jones; Prakash Mistry; Richard Faint; Deanne Thompson; Simon Cocks


Bioorganic & Medicinal Chemistry Letters | 2002

Structure–activity relationships for analogues of the phenazine-based dual topoisomerase I/II inhibitor XR11576

Shouming Wang; Warren Miller; John Milton; Nigel Vicker; Alistair J. Stewart; Peter Charlton; Prakash Mistry; David J. Hardick; William A. Denny


Journal of Medicinal Chemistry | 2004

Design and synthesis of new templates derived from pyrrolopyrimidine as selective multidrug-resistance-associated protein inhibitors in multidrug resistance.

Shouming Wang; Nan Chi Wan; John R. Harrison; Warren Miller; Irina Chuckowree; Sukhjit Sohal; Timothy Colin Hancox; Stewart Baker; Adrian Folkes; Francis Wilson; Deanne Thompson; Simon Cocks; Hayley Farmer; Anthony Boyce; Caroline Freathy; Jan Broadbridge; John W. Scott; Paul Depledge; Richard Faint; Prakash Mistry; Peter Charlton

Collaboration


Dive into the Shouming Wang's collaboration.

Top Co-Authors

Avatar

John Milton

Wellcome Trust Centre for Human Genetics

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Prakash Mistry

The Royal Marsden NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge